# Adductor Canal Block (ACB) Before and After Primary Total Knee Arthroplasty (TKA)

> **NCT02908711** · PHASE4 · COMPLETED · sponsor: **Rabin Medical Center** · enrollment: 50 (actual)

## Conditions studied

- Anesthesia, Regional

## Interventions

- **DRUG:** 0.5% ropivacaine

## Key facts

- **NCT ID:** NCT02908711
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2018-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02908711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02908711, "Adductor Canal Block (ACB) Before and After Primary Total Knee Arthroplasty (TKA)". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT02908711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*